...
首页> 外文期刊>The clinical respiratory journal. >Recent developments in pleurodesis for malignant pleural disease
【24h】

Recent developments in pleurodesis for malignant pleural disease

机译:恶性胸膜疾病血液瘤的最新发展

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract Objective Metastatic pleural effusion (MPE) is one of the most frequent causes of pleural effusion. The aims of the therapeutic management are palliation of symptoms and improvement in patient’s quality of life. The first step is a therapeutic thoracentesis. In case of a recurrent MPE, pleural maneuvers can be used to manage symptoms based on either ambulatory pleural drainage or pleurodesis to prevent fluid accumulation. The aim of this review is to describe recent advances, according to the best available evidence, in the field of pleurodesis for the management of MPE. Data source and study selection Three different searches of the most clinically relevant articles and up‐to‐date results in the field of pleurodesis for the management of MPE were performed using PubMed. Different indexing terms and time restriction were chosen. From these PubMed searches, 322 articles were respectively found. After cross‐checking these three lists and the selection of articles published after January 2010 specially dedicated to the management of MPE by pleurodesis, the abstracts of 106 articles were extracted to feed the corpus of this review. Results and conclusion Treatment approaches of recurrent MPE should take into account multiple factors in particular patient’s life expectancy and preference. If talc is the best sclerosing agent alone or in combination with indwelling pleural catheter which is a promising strategy, the pathophysiology of MPE has to be revisited in order to propose a personalized management targeting intrapleural key molecules involved in the genesis of malignant process.
机译:摘要目的转移性胸膜积液(MPE)是胸腔积液最常见的原因之一。治疗管理的目的是患者患者的生活质量的症状和改善。第一步是治疗胸腔面孔。在复发MPE的情况下,胸膜动作可用于基于车身胸腔引流或血流瘤来管理症状,以防止流体积聚。本综述的目的是根据最佳可用证据描述最新的进展,以便在MPE管理领域。数据源和学习选择三种不同的搜索最多的相关文章和最新的结果,在MPE管理的胸膜内进行的现场进行,使用PubMed进行。选择不同的索引术语和时间限制。从这些PubMed搜索,分别发现322篇文章。在交叉检查这三个清单和2010年1月后的文章的选择之后,特别致力于通过胸膜渗透到MPE的管理,提取了106篇文章的摘要以喂养本综述的语料库。结果和结论经常性MPE的处理方法应考虑到特定患者预期寿命和偏好的多种因素。如果滑石是最好的硬化剂,也与留置葡萄干导管组合是一个有希望的策略,必须重新审视MPE的病理生理学,以提出靶向涉及恶性过程的成因涉及的腹腔内关键分子的个性化管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号